Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 3/20 | 0.38 |
| ▸ | RAB9A | P51151 | 3/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10178487 | 0.82 | ALDH1A1 (0.42) | ALDH1A1USP2GAAPKMHPGD | |
| SCHEMBL10178484 | 0.82 | ESR1 (0.42) | ALDH1A1USP2GAAPKMHPGD | |
| SCHEMBL11572605 | 0.82 | ESR1 (0.42) | ESR1ESR2NPC1RAB9A | |
| SCHEMBL13652552 | 0.80 | IDO1 (0.48) | CYP2C9NPC1RAB9AL3MBTL1 | |
| SCHEMBL10178780 | 0.79 | USP2 (0.39) | ALDH1A1USP2GAAPKMHPGD | |
| SCHEMBL598140 | 0.79 | ALDH1A1 (0.52) | ALDH1A1USP2GAAPKMHPGD | |
| SCHEMBL10178574 | 0.79 | ALDH1A1 (0.40) | ALDH1A1USP2GAAPKMHPGD | |
| SCHEMBL10178571 | 0.79 | ALDH1A1 (0.40) | ALDH1A1USP2GAAPKMHPGD | |
| SCHEMBL9348164 | 0.78 | TSHR (0.52) | ALDH1A1USP2GAAPKMHPGD | |
| SCHEMBL9838746 | 0.78 | ESR1 (0.45) | ALDH1A1USP2GAAPKMHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8124310-B2 | Positive resist composition and pattern forming method using the same | FUJIFILM CORPORATION (JP) | 2012-02-28 | — | — | US | disclosed |
| US-20100069381-A1 | GSK-3BETAINHIBITOR | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-03-18 | — | — | US | disclosed |
| US-20090087784-A1 | POSITIVE RESIST COMPOSITION AND PATTERN FORMING METHOD USING THE SAME | FUJIFILM CORPORATION (JP) | 2009-04-02 | — | — | US | disclosed |
| US-7220537-B2 | Silver halide emulsion silver halide photographic sensitive material and method of image formation | KONICA MINOLTA PHOTO IMAGING, INC. (JP) | 2007-05-22 | — | — | US | disclosed |
| US-7163784-B2 | Silver halide emulsion, and silver halide color photographic material using the same | KONICA MINOLTA PHOTO IMAGING, INC. (JP) | 2007-01-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100069381-A1 | GSK-3BETAINHIBITOR | GSK3B, GSK3A, GSKIP | ALDH1A1 1473/4885USP2 4070/4885GAA 1403/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.